{"nct_id":"NCT03745716","title":"APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)","status":"COMPLETED","status_verified_date":"2025-03","start_date":"2019-01-11","start_date_type":"ACTUAL","primary_completion_date":"2020-11-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["APRE"]}